Dynavax Technologies Corporation | Small-cap | Healthcare
$9.96
-3.77%
| Dynavax Technologies Stock Comparison:
Dynavax Technologies vs ZoetisDynavax Technologies vs Haleon Plc - ADRDynavax Technologies vs BGMDynavax Technologies vs Tilray BrandsDynavax Technologies vs Phibro Animal HealthDynavax Technologies vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 95.4M
Gross Profit 81.4M 85.29%
Operating Income 14.4M 15.12%
Net Income 18.7M 19.62%
EPS (Diluted) $0.14

Balance Sheet Metrics

Total Assets 945.9M
Total Liabilities 415.0M
Shareholders Equity 530.9M
Debt to Equity 0.78

Cash Flow Metrics

Operating Cash Flow -101.7M
Free Cash Flow -23.6M

Revenue & Profitability Trend

Dynavax Technologies Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue i 277.2M 232.3M 722.7M 439.4M 46.6M
Cost of Goods Sold i 49.4M 50.2M 262.2M 173.6M 13.9M
Gross Profit i 227.8M 182.1M 460.5M 265.9M 32.6M
Gross Margin % i 82.2% 78.4% 63.7% 60.5% 70.1%
Operating Expenses
Research & Development i 61.6M 54.9M 46.6M 32.2M 28.6M
Selling, General & Administrative i 170.4M 152.9M 131.4M 100.2M 79.3M
Other Operating Expenses i - - - - -
Total Operating Expenses i 231.9M 207.8M 178.0M 132.4M 107.9M
Operating Income i -4.1M -25.7M 282.5M 133.5M -75.2M
Operating Margin % i -1.5% -11.1% 39.1% 30.4% -161.6%
Non-Operating Items
Interest Income i 36.5M 32.0M 7.9M 140.0K 1.3M
Interest Expense i 6.8M 6.8M 6.7M 11.2M 19.1M
Other Non-Operating Income 5.3M -3.9M 10.6M -44.9M 17.8M
Pre-tax Income i 30.9M -4.4M 294.3M 77.5M -75.2M
Income Tax i 3.5M 2.0M 1.1M 808.0K 0
Effective Tax Rate % i 11.5% 0.0% 0.4% 1.0% 0.0%
Net Income i 27.3M -6.4M 293.2M 76.7M -75.2M
Net Margin % i 9.9% -2.8% 40.6% 17.5% -161.6%
Key Metrics
EBITDA i 45.7M 21.0M 304.9M 149.3M -57.8M
EPS (Basic) i $0.21 $-0.05 $2.32 $0.62 $-0.75
EPS (Diluted) i $0.20 $-0.05 $1.97 $0.57 $-0.78
Basic Shares Outstanding i 130047000 128733000 126398000 116264000 100753000
Diluted Shares Outstanding i 130047000 128733000 126398000 116264000 100753000

Income Statement Trend

Dynavax Technologies Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets
Cash & Equivalents i 95.9M 150.3M 202.0M 436.2M 32.1M
Short-term Investments i 618.0M 592.0M 422.4M 109.8M 133.0M
Accounts Receivable i 45.3M 40.6M 145.1M 116.2M 22.3M
Inventory i 70.1M 53.3M 59.4M 61.3M 63.7M
Other Current Assets 18.1M 19.0M 85.6M 73.8M -
Total Current Assets i 848.9M 859.1M 917.0M 972.5M 290.0M
Non-Current Assets
Property, Plant & Equipment i 39.8M 42.9M 43.2M 41.0M 43.4M
Goodwill i 3.9M 4.1M 4.0M 4.2M 4.6M
Intangible Assets i - - - - -
Long-term Investments - - - - -
Other Non-Current Assets 74.8M 74.3M 3.5M 3.6M 3.8M
Total Non-Current Assets i 137.3M 138.0M 68.9M 66.7M 63.3M
Total Assets i 986.3M 997.1M 985.8M 1.0B 353.3M
Liabilities
Current Liabilities
Accounts Payable i 9.1M 5.2M 3.2M 2.6M 3.3M
Short-term Debt i 4.2M 4.5M 3.6M 2.6M 3.2M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities 22.0K 24.0K - 18.0M 10.7M
Total Current Liabilities i 78.6M 62.2M 150.1M 556.4M 77.4M
Non-Current Liabilities
Long-term Debt i 250.2M 252.4M 254.4M 254.8M 214.6M
Deferred Tax Liabilities i - - - - -
Other Non-Current Liabilities 244.0K 74.0K 384.0K 5.7M 2.6M
Total Non-Current Liabilities i 310.8M 312.8M 254.8M 260.5M 217.2M
Total Liabilities i 389.5M 375.0M 404.8M 816.9M 294.6M
Equity
Common Stock i 125.0K 130.0K 128.0K 123.0K 110.0K
Retained Earnings i -903.3M -930.6M -924.2M -1.2B -1.3B
Treasury Stock i - - - - -
Other Equity - - - - -
Total Shareholders Equity i 596.8M 622.1M 581.0M 222.4M 58.7M
Key Metrics
Total Debt i 254.4M 256.9M 258.0M 257.4M 217.8M
Working Capital i 770.3M 796.9M 766.9M 416.1M 212.6M

Balance Sheet Composition

Dynavax Technologies Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income i 27.3M -6.4M 293.2M 76.7M -75.2M
Depreciation & Amortization i 8.1M 7.3M 6.7M 7.1M 9.3M
Stock-Based Compensation i 52.6M 42.6M 32.9M 21.3M 13.5M
Working Capital Changes i -24.0M 46.1M -400.3M 198.4M -4.5M
Operating Cash Flow i 70.0M 90.7M -66.5M 305.1M -53.2M
Investing Activities
Capital Expenditures i -6.4M -4.1M -7.1M -9.5M -4.1M
Acquisitions i - - - - -
Investment Purchases i -524.1M -636.9M -632.3M -164.9M -201.8M
Investment Sales i 512.4M 486.1M 322.4M 187.6M 179.5M
Investing Cash Flow i -18.0M -154.9M -317.0M 13.2M -26.4M
Financing Activities
Share Repurchases i -100.0M - - - -
Dividends Paid i - - - - -
Debt Issuance i - 0 0 219.8M 0
Debt Repayment i - 0 0 -190.2M 0
Financing Cash Flow i -109.3M -6.5M 0 30.5M 108.5M
Free Cash Flow i 60.2M 96.5M 55.6M 326.1M -103.3M
Net Change in Cash i -57.4M -70.8M -383.5M 348.9M 28.9M

Cash Flow Trend

Dynavax Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 54.60
Forward P/E 28.17
Price to Book 2.41
Price to Sales 3.76
PEG Ratio 0.70

Profitability Ratios

Profit Margin -16.67%
Operating Margin 17.45%
Return on Equity -9.28%
Return on Assets 0.52%

Financial Health

Current Ratio 6.65
Debt to Equity 58.60
Beta 1.13

Per Share Data

EPS (TTM) $-0.45
Book Value per Share $4.22
Revenue per Share $2.51

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
dvax 1.2B 54.60 2.41 -9.28% -16.67% 58.60
Zoetis 65.1B 25.16 13.06 52.77% 27.83% 137.01
Haleon Plc - ADR 41.9B 20.09 5.12 9.38% 13.81% 53.41
BGM 1.9B 15.00 5.23 -16.52% -26.32% 0.22
Tilray Brands 1.9B -0.70 1.20 -88.44% -266.25% 22.07
Phibro Animal Health 1.5B 31.61 5.34 17.80% 3.72% 269.85

Financial data is updated regularly. All figures are in the company's reporting currency.